BC
LKFT

Brookfield Corp’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Brookfield Corp’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66,805
Closed -$3.68M – 690
2021
Q4 		$3.68M Buy
+66,805
New +$3.49M 0.01% 257

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brookfield Corp's LKFT Position: Q1 2022 in Review

Brookfield Corp sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2022, closing a stake of 66,805 shares — an estimated $3.68M sold.

Brookfield Corp first reported a position in LKFT in Q4 2021 and held it in 1 quarter. The position peaked at $3.68M in Q4 2021. 89 funds tracked by Wall St. Rank hold LKFT as of Q1 2022.

  • Brookfield Corp reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Brookfield Corp sold 66,805 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2022, an estimated $3.68M.
  • Brookfield Corp first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Brookfield Corp's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.68M in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.